{"id":1563,"date":"2025-12-05T14:28:17","date_gmt":"2025-12-05T14:28:17","guid":{"rendered":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/pages\/pharmacy-services\/local-negotiated-services\/enzalutamide-medication-supply\/"},"modified":"2026-01-16T13:11:48","modified_gmt":"2026-01-16T13:11:48","slug":"enzalutamide-medication-supply","status":"publish","type":"page","link":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/pages\/pharmacy-services\/local-negotiated-services\/enzalutamide-medication-supply\/","title":{"rendered":"Enzalutamide Medication Supply"},"content":{"rendered":"\n<p><strong>Service specification <\/strong><\/p>\n\n\n\n<p>Enzalutamide (brand name Xtandi\u00ae) is a specialist cancer medicine used for men with metastatic castration-resistant prostate cancer (mCRPC). The supply process in NHS Highland is tightly controlled:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Prescribing<\/strong><strong>:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Done in secondary care (urology oncology clinic) by a consultant oncologist or trained prescriber.<\/li>\n\n\n\n<li>Prescriptions are written on a Hospital-Based Prescription (HBP) form. <a href=\"https:\/\/www.communitypharmacy.scot.nhs.uk\/media\/5294\/nhs-board-service-outline-and-governance-checklist-enzalutamide.pdf\">[communityp\u2026cot.nhs.uk]<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Initial Supply:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Hospital pharmacy provides the first 5-week supply to start treatment. <a href=\"https:\/\/www.communitypharmacy.scot.nhs.uk\/media\/5294\/nhs-board-service-outline-and-governance-checklist-enzalutamide.pdf\">[communityp\u2026cot.nhs.uk]<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Community Pharmacy Role:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Each patient is linked to one nominated community pharmacy for ongoing dispensing.<\/li>\n\n\n\n<li>The Community Pharmacy Development Team (CPDT) contacts the nominated pharmacy with patient details and checks for drug interactions. <a href=\"https:\/\/www.communitypharmacy.scot.nhs.uk\/media\/5294\/nhs-board-service-outline-and-governance-checklist-enzalutamide.pdf\">[communityp\u2026cot.nhs.uk]<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Procurement<\/strong><strong>:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Enzalutamide is supplied exclusively via Astellas Pharma.<\/li>\n\n\n\n<li>Pharmacies must register with Astellas to order the drug. <a href=\"https:\/\/www.communitypharmacy.scot.nhs.uk\/media\/5294\/nhs-board-service-outline-and-governance-checklist-enzalutamide.pdf\">[communityp\u2026cot.nhs.uk]<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p><strong>Resources<\/strong><\/p>\n\n\n\n<p><strong>There are several official NHS Highland resources you can access for Enzalutamide prescribing and supply:<\/strong><\/p>\n\n\n\n<p><strong>1. NHS Highland Formulary<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The Highland Formulary lists Enzalutamide under the Malignant Disease and Immunosuppression section.<\/li>\n\n\n\n<li>It provides formulary status, approved indications, and links to Scottish Medicines Consortium (SMC) guidance.<\/li>\n\n\n\n<li>Access here: <a href=\"https:\/\/www.rightdecisions.scot.nhs.uk\/tam-treatments-and-medicines-nhs-highland\/formularies\/highland-formulary\/\">Highland Formulary \u2013 Right Decisions<\/a> <a href=\"https:\/\/www.rightdecisions.scot.nhs.uk\/tam-treatments-and-medicines-nhs-highland\/formularies\/highland-formulary\/\">[rightdecis\u2026cot.nhs.uk]<\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>2. NHS Board Service Outline &amp; Governance Checklist<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>This PDF is specific to NHS Scotland Boards, including Highland.<\/li>\n\n\n\n<li>Covers:\n<ul class=\"wp-block-list\">\n<li>Indications (mCRPC pre- and post-docetaxel)<\/li>\n\n\n\n<li>Prescribing arrangements (secondary care only)<\/li>\n\n\n\n<li>Supply process (hospital pharmacy initial 5-week supply, then nominated community pharmacy)<\/li>\n\n\n\n<li>Cost &amp; Patient Access Scheme<\/li>\n\n\n\n<li>Contact details for Astellas Pharma<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>Download: <a href=\"https:\/\/www.communitypharmacy.scot.nhs.uk\/media\/5294\/nhs-board-service-outline-and-governance-checklist-enzalutamide.pdf\">Governance Checklist \u2013 Enzalutamide<\/a> <a href=\"https:\/\/www.communitypharmacy.scot.nhs.uk\/media\/5294\/nhs-board-service-outline-and-governance-checklist-enzalutamide.pdf\">[communityp\u2026cot.nhs.uk]<\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>&nbsp;3. NHS Highland Oncology Guidelines<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Available via the Right Decisions platform.<\/li>\n\n\n\n<li>Includes cancer treatment protocols, medicines management, and monitoring guidance.<\/li>\n\n\n\n<li>Access: <a href=\"https:\/\/rightdecisions.scot.nhs.uk\/tam-treatments-and-medicines-nhs-highland\/adult-therapeutic-guidelines\/cancer\/nhs-highland-oncology-guidelines\/\">NHS Highland Oncology Guidelines<\/a> <a href=\"https:\/\/rightdecisions.scot.nhs.uk\/tam-treatments-and-medicines-nhs-highland\/adult-therapeutic-guidelines\/cancer\/nhs-highland-oncology-guidelines\/\">[rightdecis\u2026cot.nhs.uk]<\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>4. Treatments and Medicines (TAM) Portal<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Central hub for NHS Highland therapeutic guidelines, formulary updates, and patient resources.<\/li>\n\n\n\n<li>Access: <a href=\"https:\/\/www.rightdecisions.scot.nhs.uk\/tam-treatments-and-medicines-nhs-highland\/\">TAM \u2013 NHS Highland<\/a> <a href=\"https:\/\/www.rightdecisions.scot.nhs.uk\/tam-treatments-and-medicines-nhs-highland\/\">[rightdecis\u2026cot.nhs.uk]<\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>5. Specialist Pharmacy Service (SPS)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>For professional advice on medicine supply, safety, and best practice.<\/li>\n\n\n\n<li>Access: <a href=\"https:\/\/www.sps.nhs.uk\/\">SPS \u2013 Medicines Advice<\/a> <a href=\"https:\/\/www.sps.nhs.uk\/\">[sps.nhs.uk]<\/a><\/li>\n<\/ul>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"nhsuk-card__description\">Service specification Enzalutamide (brand name Xtandi\u00ae) is a specialist cancer medicine used for men with metastatic castration-resistant prostate cancer (mCRPC). [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":1481,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1563","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/pages\/1563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/comments?post=1563"}],"version-history":[{"count":5,"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/pages\/1563\/revisions"}],"predecessor-version":[{"id":1809,"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/pages\/1563\/revisions\/1809"}],"up":[{"embeddable":true,"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/pages\/1481"}],"wp:attachment":[{"href":"https:\/\/www.communitypharmacy.scot.nhs.uk\/nhs-highland\/wp-json\/wp\/v2\/media?parent=1563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}